Alternative Treatment For Bipolar II Depression: Psilocybin Safe And Effective, AMA Study Finds

By Lara Goldstein

A COMPASS Pathways (NASDAQ: CMPS )-backed clinical trial assessing psilocybin-assisted psychotherapy for bipolar II disorder has provided preliminary data on the treatment's safety and efficacy, reported Marijuana Moment's Ben Adlin.

Published by the Journal of the

You are viewing a robot-friendly page.Click hereto reload in standard format.